E. Jeff Knight's most recent trade in Alx Oncology Holdings Inc was a trade of 800,000 Stock option (right to buy) done . Disclosure was reported to the exchange on April 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Jeff E. Knight | Chief Dev & Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 800,000 | 800,000 | - | - | Stock option (right to buy) | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Dev. & Operating Officer | Sale of securities on an exchange or to another person at price $ 40.10 per share. | 08 Apr 2026 | 85,163 | 105,289 (0%) | 0% | 40.1 | 3,415,036 | Common Stock |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Dev. & Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.98 per share. | 08 Apr 2026 | 49,474 | 161,492 (0%) | 0% | 24.0 | 1,186,387 | Common Stock |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Dev. & Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 49,474 | 63,027 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Dev. & Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 19,336 | 65,977 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Dev. & Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.64 per share. | 08 Apr 2026 | 19,336 | 190,452 (0%) | 0% | 19.6 | 379,759 | Common Stock |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Dev. & Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 9,624 | 10,589 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Dev. & Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.02 per share. | 08 Apr 2026 | 9,624 | 171,116 (0%) | 0% | 20.0 | 192,672 | Common Stock |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.11 per share. | 16 Mar 2026 | 5,950 | 115,979 (0%) | 0% | 37.1 | 220,805 | Common Stock |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.77 per share. | 16 Mar 2026 | 3,961 | 112,018 (0%) | 0% | 37.8 | 149,607 | Common Stock |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 19 Mar 2025 | 6,801 | 87,852 (0%) | 0% | 34.2 | 232,390 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 19 Mar 2025 | 361 | 87,491 (0%) | 0% | 34.8 | 12,574 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 20 Feb 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 20 Feb 2025 | 43,000 | 94,653 (0%) | 0% | 0 | Common Stock | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 22 Nov 2024 | 501 | 51,653 (0%) | 0% | 56.5 | 28,317 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 15 Jul 2024 | 27,000 | 51,653 (0%) | 0% | 55 | 1,485,000 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 15 Jul 2024 | 17,499 | 70,079 (0%) | 0% | 24.0 | 419,626 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 15 Jul 2024 | 17,499 | 112,501 | - | - | Stock option (Right to Buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 15 Jul 2024 | 5,687 | 85,313 | - | - | Stock option (Right to Buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 15 Jul 2024 | 5,687 | 78,653 (0%) | 0% | 19.6 | 111,693 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 15 Jul 2024 | 2,887 | 72,966 (0%) | 0% | 20.0 | 57,798 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 15 Jul 2024 | 2,887 | 20,213 | - | - | Stock option (Right to Buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 26 Jun 2024 | 956 | 52,580 (0%) | 0% | 44.4 | 42,427 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 22 Mar 2024 | 30,000 | 84,939 (0%) | 0% | 24.0 | 719,400 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 22 Mar 2024 | 30,000 | 130,000 | - | - | Stock Option (right to buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 22 Mar 2024 | 30,000 | 54,939 (0%) | 0% | 44.2 | 1,326,600 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 22 Mar 2024 | 2,359 | 52,580 (0%) | 0% | 45.4 | 107,075 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 18 Mar 2024 | 4,283 | 54,939 (0%) | 0% | 38.1 | 163,354 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 04 Mar 2024 | 87,000 | 87,000 | - | - | Stock Option (right to buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 04 Mar 2024 | 23,000 | 59,222 (0%) | 0% | 0 | Common Stock | ||
| Crinetics Pharma Inc | E. Jeff Knight | Chief Operating Officer | 31 Dec 2023 | 931 | 36,222 (0%) | 0% | 15.0 | 13,946 | Common Stock | |
| Crinetics Pharma Inc | E. Jeff Knight | Chief Operating Officer | 31 Dec 2023 | 891 | 35,291 (0%) | 0% | 15.0 | 13,347 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 16 Mar 2023 | 587 | 34,400 (0%) | 0% | 17.1 | 10,049 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 01 Mar 2023 | 91,000 | 91,000 | - | - | Stock Option (right to buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 01 Mar 2023 | 29,500 | 34,987 (0%) | 0% | 0 | Common Stock | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 31 Dec 2022 | 537 | 5,487 (0%) | 0% | 15.2 | 8,141 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 26 Jul 2022 | 1,152 | 4,950 (0%) | 0% | 20.7 | 23,847 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 26 Jul 2022 | 1,152 | 6,102 (0%) | 0% | 17.4 | 20,091 | Common Stock | |
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 28 Feb 2022 | 23,100 | 23,100 | - | - | Stock Option (right to buy) | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 28 Feb 2022 | 4,950 | 4,950 (0%) | 0% | 0 | Common Stock | ||
| Crinetics Pharma Inc | Jeff E. Knight | Chief Operating Officer | 01 Sep 2021 | 160,000 | 160,000 | - | - | Stock Option (right to buy) |